ADGRD1 and central nervous system cancer: Importantly, GPR133 expression was detected in both IDH wild-type and IDH mutant tumors.78 Furthermore, the same study suggested a positive correlation between GPR133 expression and the WHO grade of gliomas, raising the possibility that GPR133 is a marker of anaplasia in the glioma family.